Article
Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.
AIDS (London, England) - 19 Jun 2015
Thio Chloe L, Smeaton Laura, Hollabaugh Kimberly, Saulynas Melissa, Hwang Hyon, Saravanan Shanmugam, Kulkarni Smita, Hakim James, Nyirenda Mulinda, Iqbal Hussain Syed, Lalloo Umesh G, Campbell Thomas B, Lockman Shahin, Currier Judith S
Abstract excerpt
OBJECTIVES: To explore factors associated with short and long-term hepatitis B virus (HBV) DNA suppression in a multinational cohort of HIV-HBV co-infected patients receiving HBV-active antiretrovirals. METHODS: One hundred and fifteen HIV-HBV co-infected patients participating in one of the two global randomized clinical trials conducted by the Adult AIDS Clinical Trials Group of different antiretroviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
